Skip to content

BBIO · BridgeBio Pharma, Inc.

Healthcare · −1.1% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 1 day, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive BBIO chart (by TradingView) loads here.

Our take

4 rules fired on BBIO

In short: none of these rules has solid or some evidence yet, so they show no clear lean on BBIO.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 4 rules
The 0–100 score for BBIO, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on BBIO, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of BBIO. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Congress purchases

Within earlier range

This count falls within the range of the 12 earlier comparable periods in this view.

Latest 28 days
0
Earlier median
0
Earlier range
0–1
Distinct filers per 28 daysScale: 0–1
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 0

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Sep 8, 2025. Newest disclosure across this feed: Oct 15, 2026.

Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20260Partial; excluded
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 0–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20262Partial; excluded
Jun 29, 2026–Jul 26, 20262Within stored history
Jul 27, 2026–Aug 23, 20262Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period1Within stored history
Congress purchases · Within earlier range

This count falls within the range of the 12 earlier comparable periods in this view. Earlier median: 0; range: 0–1.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20261Within stored history
May 4, 2026–May 31, 20261Within stored history
Jun 1, 2026–Jun 28, 20261Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress sales · Sparse history

Only 0 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–0.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period1Within stored history
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Public officials

Owners & lobbying

All 38 records in this snapshot
  1. Filed
  2. Filed
  3. Disclosed
    Gilbert Ray Cisneros Jr · Sale (partial)

    Transaction dated Sep 29, 2026

  4. Disclosed
    Neil Kumar · Sale

    Transaction dated Sep 17, 2026

  5. Disclosed
    Neil Kumar · Sale

    Transaction dated Sep 17, 2026

  6. Filed
  7. Filed
  8. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 18, 2026

  9. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 19, 2026

  10. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 18, 2026

  11. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 18, 2026

  12. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 18, 2026

  13. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 19, 2026

  14. Disclosed
    Neil Kumar · Sale

    Transaction dated Aug 19, 2026

  15. Filed
  16. Filed
  17. Record date
  18. Filed
  19. Filed
  20. Filed
  21. Disclosed
    Maricel Apuli · Sale

    Transaction dated Jul 30, 2026

  22. Disclosed
    Andrea Ellis · Sale

    Transaction dated Jul 9, 2026

  23. Disclosed
    Jennifer E. Cook · Sale

    Transaction dated Jul 9, 2026

  24. Disclosed
    Jennifer E. Cook · Sale

    Transaction dated Jul 9, 2026

  25. Filed
  26. Filed
  27. Filed
  28. Record date
  29. Disclosed
    Hannah Valantine · Sale

    Transaction dated Jun 22, 2026

  30. Disclosed
    Hannah Valantine · Sale

    Transaction dated Jun 23, 2026

  31. Disclosed
    Jennifer E. Cook · Sale

    Transaction dated Jun 24, 2026

  32. Disclosed
    Jennifer E. Cook · Sale

    Transaction dated Jun 23, 2026

  33. Disclosed
    Jennifer E. Cook · Sale

    Transaction dated Jun 15, 2026

  34. Disclosed
    Jennifer E. Cook · Sale

    Transaction dated Jun 15, 2026

  35. Disclosed
    Gilbert Ray Cisneros Jr · Purchase

    Transaction dated May 11, 2026

  36. Filed
  37. Disclosed
    Gilbert Ray Cisneros Jr · Purchase

    Transaction dated Apr 29, 2026

  38. Disclosed
    Gilbert Ray Cisneros Jr · Purchase

    Transaction dated Apr 29, 2026

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No member bought, 1 sold · 1 Dem

  1. ▼ SELLGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed Oct 9 · filed 10 days after the trade
See every Congress trade on BBIO →

Company insiders

0 buys · 3 sells (10 filed lots) · $4.6M sold

  1. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$89Kdisclosed Sep 21 · filed 4 days after the trade
  2. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$602Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$1.2Mdisclosed Aug 20 · filed 2 days after the trade
  4. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$679Kdisclosed Aug 20 · filed 1 day after the trade
  5. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$154Kdisclosed Aug 20 · filed 2 days after the trade
  6. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$100Kdisclosed Aug 20 · filed 2 days after the trade
  7. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$1.4Mdisclosed Aug 20 · filed 2 days after the trade
  8. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$152Kdisclosed Aug 20 · filed 1 day after the trade
  9. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$8.6Kdisclosed Aug 20 · filed 1 day after the trade
  10. ▼ SELLMaricel Apuli Chief Accounting OfficerBBIO BridgeBio Pharma, Inc.$160Kdisclosed Aug 3 · filed 4 days after the trade
See every insider trade on BBIO →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: KKR Genetic Disorder L.P. (13D amendment), Aug 17, 2026 ↗

Filings & events

Company filings (8-K) 93

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0117
  • Quarterly or yearly results · item 2.0211
  • Signed a major agreement · item 1.0110
  • Shared information with investors · item 7.015
  • Shareholder vote results · item 5.074
  • Sold shares privately · item 3.023

Filing red flags 21

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 1

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Lobbying 15

Lobbying reports filed with the Senate for the company.

$2.2M across 15 reports

Issues named in the most reports

  • Pharmacy 13
  • Health Issues 2
  • Medicare/Medicaid 2
  • Budget/Appropriations 1
  • Taxation/Internal Revenue Code 1

Planned insider sales (Form 144) 72

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

3 in the last 90 days · 72 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 14

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 11 filings
  • 13G, just holds: 3 filings

Filed most: Viking Global Investors LP (8) · KKR Genetic Disorder L.P. (3) · Farallon Capital Partners, L.P. (1) · Janus Henderson Group PLC (1)

Biggest named funds (13F)

The largest BBIO holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on BBIO

  1. ▼ SELLGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed Oct 9 · filed 10 days after the trade
  2. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$89Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$602Kdisclosed Sep 21 · filed 4 days after the trade
  4. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$1.2Mdisclosed Aug 20 · filed 2 days after the trade
  5. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$679Kdisclosed Aug 20 · filed 1 day after the trade
  6. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$154Kdisclosed Aug 20 · filed 2 days after the trade
  7. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$100Kdisclosed Aug 20 · filed 2 days after the trade
  8. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$1.4Mdisclosed Aug 20 · filed 2 days after the trade
  9. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$152Kdisclosed Aug 20 · filed 1 day after the trade
  10. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$8.6Kdisclosed Aug 20 · filed 1 day after the trade
  11. ▼ SELLMaricel Apuli Chief Accounting OfficerBBIO BridgeBio Pharma, Inc.$160Kdisclosed Aug 3 · filed 4 days after the trade
  12. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$10.1Mdisclosed Jul 13 · filed 4 days after the trade
  13. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$3Mdisclosed Jul 13 · filed 4 days after the trade
  14. ▼ SELLAndrea Ellis DirectorBBIO BridgeBio Pharma, Inc.$1.4Mdisclosed Jul 13 · filed 4 days after the trade
  15. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$2.6Mdisclosed Jun 24 · filed the same day
  16. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$151Kdisclosed Jun 24 · filed 1 day after the trade
  17. ▼ SELLHannah Valantine DirectorBBIO BridgeBio Pharma, Inc.$191Kdisclosed Jun 24 · filed 2 days after the trade
  18. ▼ SELLHannah Valantine DirectorBBIO BridgeBio Pharma, Inc.$151Kdisclosed Jun 24 · filed 1 day after the trade
  19. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$101Kdisclosed Jun 17 · filed 2 days after the trade
  20. ▼ SELLJennifer E. Cook DirectorBBIO BridgeBio Pharma, Inc.$5.9Mdisclosed Jun 17 · filed 2 days after the trade
  21. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed Jun 5 · filed 25 days after the trade
  22. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed May 8 · filed 9 days after the trade
  23. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed May 7 · filed 8 days after the trade
  24. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed Apr 7 · filed 20 days after the trade
  25. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABBIO BridgeBio Pharma, Inc.$1K–$15Kdisclosed Apr 7 · filed 19 days after the trade
See all 30 trades on BBIO →
People & votes

Which members of Congress traded BBIO, sponsored bills that touch it and voted on them — opens here.